547 related articles for article (PubMed ID: 17496199)
1. Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer.
Löffler D; Brocke-Heidrich K; Pfeifer G; Stocsits C; Hackermüller J; Kretzschmar AK; Burger R; Gramatzki M; Blumert C; Bauer K; Cvijic H; Ullmann AK; Stadler PF; Horn F
Blood; 2007 Aug; 110(4):1330-3. PubMed ID: 17496199
[TBL] [Abstract][Full Text] [Related]
2. BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription.
Brocke-Heidrich K; Ge B; Cvijic H; Pfeifer G; Löffler D; Henze C; McKeithan TW; Horn F
Oncogene; 2006 Nov; 25(55):7297-304. PubMed ID: 16732314
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation.
Brocke-Heidrich K; Kretzschmar AK; Pfeifer G; Henze C; Löffler D; Koczan D; Thiesen HJ; Burger R; Gramatzki M; Horn F
Blood; 2004 Jan; 103(1):242-51. PubMed ID: 12969979
[TBL] [Abstract][Full Text] [Related]
4. Stat1 activation attenuates IL-6 induced Stat3 activity but does not alter apoptosis sensitivity in multiple myeloma.
Dimberg LY; Dimberg A; Ivarsson K; Fryknäs M; Rickardson L; Tobin G; Ekman S; Larsson R; Gullberg U; Nilsson K; Öberg F; Wiklund HJ
BMC Cancer; 2012 Jul; 12():318. PubMed ID: 22838736
[TBL] [Abstract][Full Text] [Related]
5. Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells.
Bauer K; Kretzschmar AK; Cvijic H; Blumert C; Löffler D; Brocke-Heidrich K; Schiene-Fischer C; Fischer G; Sinz A; Clevenger CV; Horn F
Oncogene; 2009 Aug; 28(31):2784-95. PubMed ID: 19503092
[TBL] [Abstract][Full Text] [Related]
6. Ibrutinib targets microRNA-21 in multiple myeloma cells by inhibiting NF-κB and STAT3.
Ma J; Gong W; Liu S; Li Q; Guo M; Wang J; Wang S; Chen N; Wang Y; Liu Q; Zhao H
Tumour Biol; 2018 Jan; 40(1):1010428317731369. PubMed ID: 29320977
[TBL] [Abstract][Full Text] [Related]
7. A novel distal enhancer mediates cytokine induction of mouse RANKl gene expression.
Bishop KA; Meyer MB; Pike JW
Mol Endocrinol; 2009 Dec; 23(12):2095-110. PubMed ID: 19880655
[TBL] [Abstract][Full Text] [Related]
8. IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma.
Chong PSY; Zhou J; Lim JSL; Hee YT; Chooi JY; Chung TH; Tan ZT; Zeng Q; Waller DD; Sebag M; Chng WJ
Cancer Res; 2019 Sep; 79(18):4679-4688. PubMed ID: 31337650
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel miR-21 target proteins in multiple myeloma cells by quantitative proteomics.
Xiong Q; Zhong Q; Zhang J; Yang M; Li C; Zheng P; Bi LJ; Ge F
J Proteome Res; 2012 Apr; 11(4):2078-90. PubMed ID: 22316494
[TBL] [Abstract][Full Text] [Related]
10. Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signalling.
Gupta N; Kumar R; Seth T; Garg B; Sharma A
RNA Biol; 2020 Jan; 17(1):98-111. PubMed ID: 31532704
[TBL] [Abstract][Full Text] [Related]
11. As
Wu D; Dong W; Fang K; Wang M
Technol Cancer Res Treat; 2019; 18():1533033819896806. PubMed ID: 31868118
[TBL] [Abstract][Full Text] [Related]
12. STAT3-induced long noncoding RNAs in multiple myeloma cells display different properties in cancer.
Binder S; Hösler N; Riedel D; Zipfel I; Buschmann T; Kämpf C; Reiche K; Burger R; Gramatzki M; Hackermüller J; Stadler PF; Horn F
Sci Rep; 2017 Aug; 7(1):7976. PubMed ID: 28801664
[TBL] [Abstract][Full Text] [Related]
13. The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells.
Slørdahl TS; Abdollahi P; Vandsemb EN; Rampa C; Misund K; Baranowska KA; Westhrin M; Waage A; Rø TB; Børset M
Oncotarget; 2016 May; 7(19):27295-306. PubMed ID: 27036022
[TBL] [Abstract][Full Text] [Related]
14. IL-6-induced Bcl6 variant 2 supports IL-6-dependent myeloma cell proliferation and survival through STAT3.
Tsuyama N; Danjoh I; Otsuyama K; Obata M; Tahara H; Ohta T; Ishikawa H
Biochem Biophys Res Commun; 2005 Nov; 337(1):201-8. PubMed ID: 16188230
[TBL] [Abstract][Full Text] [Related]
15. Ginkgolic Acid C 17:1, Derived from Ginkgo biloba Leaves, Suppresses Constitutive and Inducible STAT3 Activation through Induction of PTEN and SHP-1 Tyrosine Phosphatase.
Baek SH; Lee JH; Kim C; Ko JH; Ryu SH; Lee SG; Yang WM; Um JY; Chinnathambi A; Alharbi SA; Sethi G; Ahn KS
Molecules; 2017 Feb; 22(2):. PubMed ID: 28208828
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of interleukin-6 signaling with CNTO 328 enhances the activity of bortezomib in preclinical models of multiple myeloma.
Voorhees PM; Chen Q; Kuhn DJ; Small GW; Hunsucker SA; Strader JS; Corringham RE; Zaki MH; Nemeth JA; Orlowski RZ
Clin Cancer Res; 2007 Nov; 13(21):6469-78. PubMed ID: 17975159
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of miR-144/199 promote myeloma pathogenesis via upregulation of versican and FAK/STAT3 signaling.
Gupta N; Kumar R; Sharma A
Mol Cell Biochem; 2021 Jun; 476(6):2551-2559. PubMed ID: 33649985
[TBL] [Abstract][Full Text] [Related]
18. Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells.
Fagerli UM; Ullrich K; Stühmer T; Holien T; Köchert K; Holt RU; Bruland O; Chatterjee M; Nogai H; Lenz G; Shaughnessy JD; Mathas S; Sundan A; Bargou RC; Dörken B; Børset M; Janz M
Oncogene; 2011 Jul; 30(28):3198-206. PubMed ID: 21478911
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway.
Brock M; Trenkmann M; Gay RE; Michel BA; Gay S; Fischler M; Ulrich S; Speich R; Huber LC
Circ Res; 2009 May; 104(10):1184-91. PubMed ID: 19390056
[TBL] [Abstract][Full Text] [Related]
20. Patrinia scabiosaefolia extract suppresses proliferation and promotes apoptosis by inhibiting the STAT3 pathway in human multiple myeloma cells.
Peng J; Chen Y; Lin J; Zhuang Q; Xu W; Hong Z; Sferra TJ
Mol Med Rep; 2011; 4(2):313-8. PubMed ID: 21468570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
